Just Breathe: Supplemental Oxygen Provides No Benefit in Acute Myocardial Infarction

From Urgent Matters:

The DETO2X-AMI study showed that administering supplemental oxygen to non-hypoxic patients with suspected AMIs did not improve mortality at either one month or one year.  Additionally, administration of oxygen did not appear to affect infarct size as both groups had similar troponin levels.  To date, the DETO2X-AMI trial is the largest randomized controlled clinical that evaluates the use of supplemental oxygen in AMI.  Its findings cast doubt on the benefit of routine oxygen therapy in these patients.  With this evidence, clinicians should consider supplemental oxygen ineffective in AMI patients without hypoxia, and ultimately it may be removed from clinical guidelines.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: